Wide Ranks

ICAD

icad inc.

1.77

Top Statistics
Market Cap 46 M Forward PE -7.18 Revenue Growth 20.60 %
Current Ratio 4.24 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -12.13 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -5.80 Enterprise / Revenue 1.45 Price To Sales Trailing12 Months 2.48
Profitability
Profit Margins -12.13 % Operating Margins -38.73 %
Balance Sheet
Total Cash 20 M Total Cash Per Share 0.7720 Total Debt 469000
Total Debt To Equity 1.51 Current Ratio 4.24 Book Value Per Share 1.27
All Measures
Short Ratio 151.00 % Message Board Id finmb_279728 Shares Short Prior Month 216726
Return On Equity -0.1486 City Nashua Uuid 80717a59-1610-3b96-942e-6a1f92e0ac99
Previous Close 1.73 First Trade Date Epoch Utc 471 M Book Value 1.27
Beta 1.48 Total Debt 469000 Volume 401509
Price To Book 1.40 Last Split Date 1 B Fifty Two Week Low 1.18
Total Cash Per Share 0.7720 Total Revenue 18 M Shares Short Previous Month Date 1 B
Target Median Price 3.00 Audit Risk 8 Max Age 86400
Recommendation Mean 1.25 Sand P52 Week Change 0.3133 Operating Margins -38.73 %
Target Mean Price 4.38 Net Income To Common -4542000 Short Percent Of Float 0.0096
Implied Shares Outstanding 28 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 506380 Average Volume10days 506380 Total Cash 20 M
Next Fiscal Year End 1 B Revenue Per Share 0.7180 Held Percent Insiders 0.0563
Ebitda Margins -24.93 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Share Holder Rights Risk 3 Regular Market Previous Close 1.73
Target Low Price 2.50 Gmt Off Set Milliseconds -18000000 Fifty Day Average 1.72
Open 1.72 Free Cashflow -2944125 State NH
Dividend Yield 0.00 % Return On Assets -0.0767 Time Zone Short Name EST
Board Risk 5 Trailing Eps -0.2000 Day Low 1.61
Address1 98 Spit Brook Road Shares Outstanding 26 M Compensation Risk 7
Price Hint 4 Target High Price 9.00 Website https://www.icadmed.com
52 Week Change 0.0994 Average Volume 211050 Forward Eps -0.2100
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 392.50 %
Last Split Factor 1:5 Regular Market Day High 1.78 Is_sp_500 False
Profit Margins -12.13 % Debt To Equity 1.51 Fifty Two Week High 2.65
Day High 1.78 Shares Short 249087 Regular Market Open 1.72
Industry Key medical-devices Earnings Growth 0.00 % Enterprise To Revenue 1.45
Revenue Growth 20.60 % Shares Percent Shares Out 0.0095 Operating Cashflow -4142000
Currency USD Time Zone Full Name America/New_York Market Cap 46 M
Is_nasdaq_100 False Zip 03062 Quote Type EQUITY
Industry Medical Devices Long Name iCAD, Inc. Overall Risk 5
Regular Market Day Low 1.61 Held Percent Institutions 0.2716 Current Price 1.77
Address2 Suite 100 Enterprise To Ebitda -5.80 Financial Currency USD
Current Ratio 4.24 Gross Margins 87.08 % Industry Disp Medical Devices
Number Of Analyst Opinions 4 Country United States Float Shares 24 M
Two Hundred Day Average 1.57 Governance Epoch Date 1 B Enterprise Value 27 M
Price To Sales Trailing12 Months 2.48 Forward PE -7.18 Regular Market Volume 401509
Ebitda -4686000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States.

It operates through two segments, Detection and Therapy.

The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.

The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002.

iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.